IPO

The thrift giant posts strong U.S. sales and a second quarter of adjusted profit growth, but a net loss and Canadian weakness reveal ongoing challenges.

HighPeak Energy posted strong Q1 operational results, but a $157M derivative loss highlights the challenges of navigating a volatile, geopolitically charged market.

The diagnostics firm's stellar quarter is fueled by surging test volumes and a new non-invasive prenatal test poised to disrupt high-risk screening.

LifeMD posts record subscriber growth in Q1 driven by GLP-1 and women's health, but a planned loss from heavy marketing spend raises key questions.

Nitro's new MCP connector for Claude AI promises to automate complex document tasks with a single prompt, targeting a major productivity pain point in enterprise AI.

With a new $100M fund, Global Millennial Capital is betting big on mature, private tech firms in AI and DeFi, a market segment often overlooked.

Now the #2 aligner company globally, Angel Aligner leverages 23+ years of R&D and strategic expansion to challenge industry leaders. Here's how.

The builder debuts 13 model homes starting at $1.5M in Great Park, betting on Irvine's blend of elite schools, amenities, and resilient market demand.

BioAdaptives completes its MyndSystem™ with a new nighttime nootropic, aiming to capture the overlooked market for overnight brain recovery.

As it prepares to go public, autonomous defense firm Powerus adds fmr. Naval Special Warfare Commander Jamie Sands to its board to close the tech gap.

With a promising cancer pipeline, Crescent Biopharma heads to key May conferences to prove its strategy against fierce competition in the bispecific and ADC markets.

Five years in, digital bank Mox turns a profit and unveils Mox+, a wealth solution for young professionals, signaling a new era for fintech in Hong Kong.

The solar giant commissioned a landmark 1.1 GW in one year, boosting India's 500 GW goal and expanding into battery storage and green hydrogen.

A new AI platform uses patient simulations to train clinicians in tough end-of-life talks, promising more compassionate and consistent patient care.

An 80-year-old packaging giant launches New Earth Ventures, a fund to back the AI, automation, and biomaterials set to reinvent the global supply chain.

Record applications for Spark Grants reveal a deep need for inclusive access to nature. See how public funds are helping diverse communities connect with parks.

With a novel 'NewCo' model and key partnerships, Banyan BioInnovations aims to de-risk and accelerate clinical-stage drugs past the funding valley of death.

A traditional Chinese steel manufacturer is pivoting to the high-stakes world of clean energy. Can it transform its industrial might into a green future?

Forrester's new report highlights Airia as enterprises grapple with governing the new wave of autonomous, agentic AI systems that defy old rules.

Apollo's massive new fund isn't just a win for the firm; it signals a major shift in how companies finance growth in a volatile, high-rate world.